Table 1.

Clinical and pathological characteristics of the patients related to the size of the tumor.

	Tumor size ≤ 2 cm (1,471)	Tumor size >2 and ≤4 cm (1,624)	Tumor size >4 cm (1,438)	P
Age (years)	46.7 ± 9.4	48.9 ± 9.8	49.2 ± 9.7	0.000
Menopausal state				0.000
Yes	497	696	612
No	974	928	826
BMI (kg/m2)	21.7 ± 3.3	22.3 ± 3.5	22.1 ± 3.6	0.000
FIGO				0.000
≤ IB1	1366	0	0
IB2	0	1287	0
IB3	0	0	958
IIA1	105	337	0
IIA2	0	0	487
Parametrial involvement				0.000
Positive	18 (1.2%)	101 (6.2%)	322 (22.4%)
Negative	1453 (98.8%)	1523 (93.8%)	1116 (77.6%)
Depth of stromal invasive				0.000
≥1/2	194 (13.2%)	1061 (65.3%)	1292 (89.8%)
<1/2	1277 (86.8%)	563 (34.7%)	146 (10.2%)
Infiltration into vagina				0.000
Positive	105 (7.1%)	337 (20.8%)	480 (33.4%)
Negative	1366 (92.9%)	1287 (79.2%)	958 (66.6%)
Surgical vaginal margin				0.000
Positive	41 (2.8%)	136 (8.4%)	180 (12.5%)
Negative	1430 (97.2%)	1488 (91.6%)	1258 (87.5%)
Status of pelvic lymph nodes				0.000
Positive	78 (5.3%)	288 (17.7%)	593 (41.2%)
Negative	1393 (94.7%)	1336 (82.3%)	845 (58.8%)
Histological subtype				0.000
Squamous cell cancer	1115 (75.8%)	1349 (83.1%)	1213 (84.4%)
Adenocarcinoma	268 (18.2%)	180 (11.1%)	157 (10.9%)
Adenosequamous cancer	76 (5.2%)	75 (4.6%)	56 (3.9%)
Other subtype	12 (0.8%)	20 (1.2%)	12 (0.8%)
Infiltration into uterine body				0.000
Positive	39 (2.7%)	219 (13.5%)	474 (33%)
Negative	1432 (97.3%)	1405 (86.5%)	964 (67%)
Lymph vascular space invasion				0.000
Positive	299 (20.3%)	887 (64.6%)	917 (63.8%)
Negative	1172 (79.7%)	737 (45.4%)	521 (36.2%)
Recurrence				0.000
Positive	29 (2.0%)	101 (6.2%)	199 (13.8%)
Negative	1433 (97.4%)	1504 (92.6%)	1194 (83.0%)
Unknown	9 (0.6%)	19 (1.2%)	45 (3.2%)
Survival state				0.000
Death	28 (1.9%)	105 (6.5%)	233 (16.2%)
Live	1443 (98.1%)	1519 (93.5%)	1205 (83.8%)
Unknown	0 (0%)	0 (0%)	0 (0%)